Concept and contents by Sonja Duggen and Cordula Klemm

Any suggestions or questions? Tweet us @helmholtzMucEn

Imprint

The one-day Oktoberfest Symposium is small but exclusive. Clinical researchers and scientists of world renown convene in Munich at the invitation of Helmholtz Zentrum München, Institute of Diabetes Research, the Diabetes Research Group of Technische Universität München and the Diabetes Research Group e.V.

The development, diagnosis and prevention of diabetes type 1 and gestational diabetes are central themes of the Oktoberfest Symposium. The focus of the ninth meeting is the early diagnosis of the disease in children by appropriate markers.

Learn more about Fr1da

Early Diagnosis Helps to Avert Damage Caused by Type 1 Diabetes

At the Oktoberfest Symposium studies for an early diagnosis for type 1 diabetes in children are presented. Four immunological markers are currently being tested in the world's first comprehensive type 1 diabetes screening study Fr1da.

Get to know type 1 diabetes prevention studies

Learn more about Fr1da

The Fr1da study examines blood samples of up to 100 000 children between three and four years of age for early immunological markers of the disease. An insulin vaccination shall delay or prevent the outbreak of the disease in children who test positive. Additional prevention strategies, such as the treatment of type 1 diabetes include genetic and biochemical markers, the activation of immune cells and regenerative methods.

 

 

 

Anette-Gabriele Ziegler

“With the Oktoberfest Symposium, we bring outstanding, internationally recognized speakers to Munich. We invite speakers both inside and outside our discipline in order to explore exciting cooperation opportunities for major studies in which we are involved. One of our most important programs revolves around finding early markers for type 1 diabetes in children. An early diagnosis helps delay the disease or to treat it in time. Strategies for the prevention of type 1 diabetes are already being tested in clinical trials. ”

Anette-Gabriele Ziegler is director of the Institute of Diabetes Research at Helmholtz Zentrum München, holds the chair of Diabetes and Gestational Diabetes at Technische Universität München and is clinical director of the Helmholtz Diabetes Center

 

 

Ezio Bonifacio

“We invite speakers who are closely related to our studies. We have similar goals and utilize new results to make our studies more international and to improve our study design. We dress in traditional costume. That makes the atmosphere more relaxed and is a starting point for conversation. It breaks the ice and makes it easier for the young scientists to talk with the international luminaries. ”

Ezio Bonifacio is professor and group leader at the DFG Center for Regenerative Therapies at Technische Universität Dresden. At Helmholtz Zentrum München he leads the research group “Immunobiology of Diabetes”, which is based at the Institute for Diabetes and Obesity

Richard Oram

“At the Oktoberfest Symposium I meet top experts in the field of the biology of type 1 diabetes. The Fr1da and TEDDY studies presented here are very important for an early diagnosis of type 1 diabetes and for a better understanding of the pathogenesis of the disease. From the presentations and discussions, we develop approaches for joint studies and data evaluations, which should make better treatment of the disease possible. ”

Richard Oram is a clinical researcher and teaches at the University of Exeter Medical School. His research activities focus on endogenous insulin production in type 1 diabetes patients.

Together for New Diagnostic and Treatment Options

The name of the Oktoberfest Symposium is part of the program. Many of the participants come in traditional costume. In a relaxed atmosphere, they exchange ideas about current research approaches and new study results with regard to type 1 diabetes. New collaborations across borders and disciplines lead to a better understanding of the autoimmune disease and to new diagnostic and treatment options.